| NOW |
Report |
Subscription revenue |
IN-LINE |
pred ~$3.84B vs. cons $3.82B |
MEDIUM |
| NOW |
Report |
cRPO constant-currency growth |
BEAT |
pred ~20.5% vs. cons 19.7% |
MEDIUM |
| NOW |
Report |
Non-GAAP operating margin |
BEAT |
pred ~27.1% vs. cons 26.7% |
MEDIUM |
| NOW |
Guide |
FY26 subscription revenue |
LOWER |
guide ~$15.80B vs. cons $15.84B (FY26) |
MEDIUM |
| NOW |
Guide |
Q3 cRPO constant-currency growth |
LOWER |
guide ~19.0% vs. cons 19.6% (Q3 2026) |
MEDIUM |
| NOW |
Guide |
FY26 non-GAAP operating margin |
BETTER |
guide ~31.7% vs. cons 31.5% (FY26) |
MEDIUM |
| NOW |
Guide |
FY26 Now Assist AI ACV target |
UNCHANGED |
guide ~$1.50B vs. cons $1.50B (FY26) |
MEDIUM |
| NOW |
Return |
Day-1 residual (stock − beta × S&P 500) |
-3.5% |
— |
MEDIUM |
| NOW |
Return |
5-day cumulative residual |
-5.5% (FOLLOW-THROUGH) |
A cRPO and margin beat is likely to be outweighed by ~0.6-point-lower Q3 cRPO guidance and FY26 subscription revenue guidance of ~$15.80B versus ~$15.84B consensus; that implies modest out-period estimate cuts despite the quarterly beat. |
MEDIUM |